U.S., Dec. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07282769) titled 'Semaglutide (Wegovy) Treatment for Trichotillomania' on Dec. 05.
Brief Summary: This research study is testing the effectiveness and safety of semaglutide (Wegovy) in people with trichotillomania, also known as hair-pulling disorder.
Study Start Date: Feb., 2026
Study Type: INTERVENTIONAL
Condition:
Trichotillomania (Hair-Pulling Disorder)
Trichotillomania
Hair Pulling Disorder
Hair Pulling
Hair-Pulling Disorder
Intervention:
DRUG: Semaglutide
All participants in the study will receive semaglutide (Wegovy).
Recruitment Status: NOT_YET_RECRUITING
Sponsor: University of Chicago
Published by HT Digital Content Services with p...